Drug interaction alerts in software - What do general practitioners and pharmacists want?

Medical Journal of Australia

Volumn 195, Issue 11, 2011, Pages 676-680

  Yu, Kitty H ^a   Sweidan, Michelle ^a   Williamson, Margaret ^b   Fraser, Amanda ^c  

^a National Prescribing Service   (Australia)

^b National Prescribing Service   (Australia)

^c South Yarra Medical   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; COMPUTER PROGRAM; DECISION SUPPORT SYSTEM; DRUG INTERACTION; DRUG PREFERENCE; DRUG SAFETY; FEMALE; GENERAL PRACTITIONER; HUMAN; MALE; MEDICAL INFORMATION SYSTEM; PHARMACIST ATTITUDE; PHYSICIAN ATTITUDE; PRESCRIPTION;

EID: 84857067619     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja11.10206     Document Type: Article

References (25)

1. New South Wales Department of Health. Safety notice: 011/09. Allopurinol and azathioprine. 7 May 2009. http://www.health.nsw.gov.au/resources/quality/sabs/pdf/sn20090507.pdf (accessed Nov 2011).
2. Pilgrim JP, Gerostamoulos D, Drummer OH. Deaths involving contraindicated and inappropriate combinations of serotonergic drugs. Int J Legal Med 2011; 125: 803-815.
3. Saverno KR, Hines LE, Warholak TL, et al. Ability of pharmacy clinical decision-support software to alert users about clinically important drugdrug interactions. J Am Med Inform Assoc 2010; 18: 32-37.
4. Sweidan M, Reeve JF, Brien JE, et al. Quality of drug interaction alerts in prescribing and dispensing software. Med J Aust 2009; 190: 251-254.
5. Ahearn MD, Kerr SJ. General practitioners' perceptions of the pharmaceutical decisionsupport tools in their prescribing software. Med J Aust 2003; 179: 34-37.
6. Lapane KL, Waring ME, Schneider KL, et al. A mixed method study of the merits of e-prescribing drug alerts in primary care. J Gen Intern Med 2008; 23: 442-446.
7. Magnus D, Rodgers S, Avery AJ. GPs' views on computerized drug interaction alerts: questionnaire survey. J Clin Pharm Ther 2002; 27: 377-382.
8. Glassman PA, Belperio P, Simon B, et al. Exposure to automated drug alerts over time: effects on clinicians' knowledge and perceptions. Med Care 2006; 44: 250-256.
9. Weingart SN, Massagli M, Cyrulik A, et al. Assessing the value of electronic prescribing in ambulatory care: a focus group study. Int J Med Inform 2009; 78: 571-578.
10. Moxey A, Robertson J, Newby D, et al. Computerized clinical decision support for prescribing: provision does not guarantee uptake. J Am Med Inform Assoc 2010; 17: 25-33.
11. Russ AL, Zillich AJ, McManus MS, et al. A human factors investigation of medication alerts: barriers to prescriber decision-making and clinical workflow. AMIA Annu Symp Proc 2009; 2009: 548-552.
12. Seidling HM, Phansalkar S, Seger DL, et al. Factors influencing alert acceptance: a novel approach for predicting the success of clinical decision support. J Am Med Inform Assoc 2011; 18: 479-484.
13. Glaziou P. Sample size for a prevalence survey, with finite population correction. http://sampsize.sourceforge.net/iface/index.html.(accessed Mar 2010).
14. Paterno MD, Maviglia SM, Gorman PN, et al. Tiering drug-drug interaction alerts by severity increases compliance rates. J Am Med Inform Assoc 2009; 16: 40-46.
15. Vitry AI. Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol 2007; 63: 709-714.
16. Wang LM, Wong M, Lightwood JM, et al. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs. Ann Pharmacother 2010; 44: 28-34.
17. Abarca J, Malone DC, Armstrong EP, et al. Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc (2003) 2004; 44: 136-141.
18. Weingart SN, Toth M, Sands DZ, et al. Physicians'decisions to override computerized drug alerts in primary care. Arch Intern Med 2003; 163: 2625-2631.
19. Weingart SN, Simchowitz B, Shiman L, et al. Clinicians' assessments of electronic medication safety alerts in ambulatory care. Arch Intern Med 2009; 169: 1627-1632.
20. Cash JJ. Alert fatigue. Am J Health Syst Pharm 2009; 66: 2098-2101.
21. Bergk V, Gasse C, Schnell R, et al. Requirements for a successful implementation of drug interaction information systems in general practice: results of a questionnaire survey in Germany. Eur J Clin Pharmacol 2004; 60: 595-602.
22. Indermitte J, Erba L, Beutler M, et al. Management of potential drug interactions in community pharmacies: a questionnaire-based survey in Switzerland. Eur J Clin Pharmacol 2007; 63: 297-305.
23. Ko Y, Abarca J, Malone DC, et al. Practitioners' views on computerized drug-drug interaction alerts in the VA system. J Am Med Inform Assoc 2007; 14: 56-64.
24. Murphy JE, Forrey RA, Desiraju U. Community pharmacists' responses to drug-drug interaction alerts. Am J Health Syst Pharm 2004; 61: 1484-1487.
25. Abarca J, Malone DC, Skrepnek GH, et al. Community pharmacy managers' perception of computerized drug-drug interaction alerts. J Am Pharm Assoc (2003) 2006; 46: 148-153.